STAT3 activation, chemokine receptor expression, and cyclin-Cdk function in B-1 cells

Current Topics in Microbiology and Immunology

Volumn 252, Issue , 2000, Pages 121-130

  Rothstein, T L ^a   Fischer, G M ^a   Tanguay, D A ^a   Pavlovic, S ^a   Colarusso, T P ^a   Gerstein, R M ^a   Clarke, S H ^a   Chiles, T C ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CYCLIN D2; CYCLIN DEPENDENT KINASE; CYCLINE; STAT3 PROTEIN;

B LYMPHOCYTE; CONFERENCE PAPER; HUMAN; LYMPHOCYTE SUBPOPULATION; PERITONEUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SPLEEN;

EID: 0033757286     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-57284-5_13     Document Type: Conference Paper

References (46)

1. Cd5+ B (B-1) cells and immunity
2. Origin of murine B cell lineages
3. B-1 cells are made, not born
4. Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies
5. Murine B cell differentiation lineages
6. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells
7. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly- 1 B cell lineage
8. Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: Two B-cell activation pathways
9. Development of B-1 cells Segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression
10. Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals
11. In vivo effects of hyperdiploid Ly-1- B cells of NZB origin
12. A new human T-cell differentiation antigen: Unexpected expression on chronic lymphocytic leukemia cells
13. Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: A comparative study
14. B-Ly1 cells: Immortal Ly-1+ B lymphocyte cell lines spontaneously arising in murine splenic cultures
15. Stimulation of murine B cells by the combination of calcium ionophore plus phorbol ester
16. Peritoneal B cells respond to phorbol esters in the absence of co-mitogen
17. Activation and proliferation signals in mouse B cells. VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristate acetate
18. Anti-Ig antibody inhibits the phorbol ester-induced stimulation of peritoneal B cells
19. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells
20. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes
21. Constitutive and inducible levels of egr-1 and c-myc early growth response gene expression in self-renewing B-1 lymphocytes
22. Elevated levels of protein kinase C activity and alpha-isoenzyme expression in murine peritoneal B cells
23. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes
24. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation
25. Chemokines: Signal lamps for trafficking of T and B cells for development and effector function
26. Chemokines, leukocyte trafficking, and inflammation
27. Characterization of the CCR2 chemokine receptor: Functional CCR2 receptor expression in B cells
28. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D- type cyclin in mature B lymphocytes
29. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes
30. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types
31. Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes
32. Proliferation-independent induction of macrophage cyclin D2, and repression of cyclin D1, by lipopolysaccharide
33. Principles of CDK regulation
34. CDK inhibitors: Positive and negative regulators of G1-phase progression
35. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling
36. Activation and association of Stat3 with Src in v-Src-transformed cell lines
37. Stat3 activation is required for cellular transformation by v-src
38. Stat3 as an oncogene
39. Jaks and STATs: Biological implications
40. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
41. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation
42. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats
43. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis
44. P210 and P190(BCP,/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
45. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues